Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$4.05
+2.27%
Mkt Cap $1.19B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $8.42M | $4.58M | -45.56% | -$0.10 | -$0.01 | +90.00% | — | — |
| Q4 2025 Nov 13, 2025 | $8.29M | $2.92M | -64.73% | -$0.08 | -$0.11 | -37.50% | — | — |
| Q3 2025 Aug 12, 2025 | $933.33K | $856.00K | -8.29% | -$0.14 | -$0.11 | +21.43% | — | — |
| Q2 2025 May 14, 2025 | $500.00K | $1.34M | +168.20% | -$0.08 | -$0.07 | +12.50% | — | — |
| Q1 2025 Mar 19, 2025 | $733.33K | $1.19M | +62.27% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q4 2024 Nov 14, 2024 | $1.30M | $953.00K | -26.69% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q3 2024 Aug 14, 2024 | $1.28M | $717.00K | -43.98% | -$0.09 | -$0.10 | -11.11% | — | — |
| Q2 2024 May 14, 2024 | $1.48M | $1.06M | -28.04% | -$0.09 | -$0.10 | -11.11% | — | — |
| Q1 2024 Feb 13, 2024 | — | $1.23M | — | -$0.08 | -$0.13 | -62.50% | — | — |
| Q4 2023 Nov 9, 2023 | $1.70M | $1.38M | -18.88% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | $2.18M | $1.77M | -18.94% | -$0.10 | -$0.08 | +20.00% | — | — |
| Q2 2023 May 10, 2023 | $2.22M | $1.85M | -16.62% | -$0.08 | -$0.10 | -25.00% | — | — |
| Q1 2023 Mar 6, 2023 | $6.21M | $1.76M | -71.61% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q4 2022 Nov 9, 2022 | $2.72M | $16.72M | +514.78% | $0.10 | -$0.04 | -140.00% | — | — |
| Q3 2022 Aug 8, 2022 | $22.54M | $2.91M | -87.08% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2022 May 9, 2022 | $28.32M | $32.02M | +13.05% | -$0.14 | -$0.10 | +28.57% | — | — |
| Q1 2022 Mar 1, 2022 | $24.30M | $24.22M | -0.34% | -$0.14 | -$0.13 | +7.14% | — | — |
| Q4 2021 Nov 8, 2021 | $23.86M | $21.56M | -9.64% | -$0.14 | -$0.15 | -7.14% | — | — |
| Q3 2021 Aug 9, 2021 | $33.58M | $33.58M | +0.00% | -$0.12 | -$0.01 | +91.61% | — | — |
| Q2 2021 May 10, 2021 | $19.14M | $24.51M | +28.06% | -$0.16 | -$0.11 | +31.25% | — | — |